Renaissance Technologies
SHPH icon

Renaissance Technologies’s Shuttle Pharmaceuticals SHPH Stock Holding History

Renaissance Technologies’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$7K – 3914
2024
Q1 		$7K Sell
8
-6
-43% -$5.05K ﹤0.01% 3643
2023
Q4 		$13K Buy
+14
New +$14.3K ﹤0.01% 3621

Other funds holding SHPH

TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies's SHPH Position: Q2 2024 in Review

Renaissance Technologies sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2024, closing a stake of 8 shares — an estimated $7K sold.

Renaissance Technologies first reported a position in SHPH in Q4 2023 and held it in 2 quarters. The position peaked at $13K in Q4 2023. 3 funds tracked by Wall St. Rank hold SHPH as of Q2 2024.

  • Renaissance Technologies reported no remaining Shuttle Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 8 Shuttle Pharmaceuticals shares in Q2 2024, an estimated $7K.
  • Renaissance Technologies first reported a position in Shuttle Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Renaissance Technologies's Shuttle Pharmaceuticals position peaked at $13K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.